BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 15070597)

  • 21. Prognostic value of the ratio of metastatic lymph nodes in gastric cancer: an analysis based on a Chinese population.
    Wang X; Wan F; Pan J; Yu GZ; Chen Y; Wang JJ
    J Surg Oncol; 2009 May; 99(6):329-34. PubMed ID: 19208438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The study of the minimum number of examined lymph nodes for the TNM classification of gastric cancer].
    Chen B; Sun JY; Jin F; Xu HM; Wang SB
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):702-5. PubMed ID: 16008956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
    Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
    Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
    Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
    J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognosis of gastric cardia cancer after R0 resection.
    An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Am J Surg; 2010 Jun; 199(6):725-9. PubMed ID: 19837398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
    Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multi-antibody combined determination of lymph node micrometastasis in patients with gastric cancer].
    Wang GY; Wang SJ; Li Y; Wang LL; Wang XL; Song ZC; Fan LQ
    Ai Zheng; 2004 May; 23(5):559-63. PubMed ID: 15142454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
    Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
    Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracapsular lymph node spread: a new prognostic factor in gastric cancer.
    Alakus H; Hölscher AH; Grass G; Hartmann E; Schulte C; Drebber U; Baldus SE; Bollschweiler E; Metzger R; Mönig SP
    Cancer; 2010 Jan; 116(2):309-15. PubMed ID: 19950124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
    Aurello P; D'Angelo F; Rossi S; Bellagamba R; Cicchini C; Nigri G; Ercolani G; De Angelis R; Ramacciato G
    Am Surg; 2007 Apr; 73(4):359-66. PubMed ID: 17439029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience.
    Hung FC; Kuo CM; Chuah SK; Kuo CH; Chen YS; Lu SN; Chang Chien CS
    J Gastroenterol Hepatol; 2007 May; 22(5):724-8. PubMed ID: 17444863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    Ann Surg Oncol; 2007 May; 14(5):1688-93. PubMed ID: 17245613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effect of lymph node metastasis classified by the anatomical site or by the number of nodes involved on prognosis of patients with gastric cancer.
    Hidaka H; Eto T; Maehara N; Jimi S; Hotokezaka M; Chijiiwa K
    Hepatogastroenterology; 2008; 55(88):2269-72. PubMed ID: 19260520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Systematic lymphadenectomy in stomach carcinoma--staging and therapy].
    Jähne J; Maschek H; Meyer HJ; Pichlmayr R
    Zentralbl Chir; 1996; 121(2):126-30. PubMed ID: 8868608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction.
    Heeren PA; Kelder W; Blondeel I; van Westreenen HL; Hollema H; Plukker JT
    Eur J Surg Oncol; 2005 Apr; 31(3):270-6. PubMed ID: 15780562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
    Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
    Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First drainage lymph node(s) in gastric cancer: analysis of the topographical pattern of lymph node metastasis in patients with pN-1 stage tumors.
    Kikuchi S; Kurita A; Natsuya K; Sakuramoto S; Kobayashi N; Shimao H; Kakita A
    Anticancer Res; 2003; 23(1B):601-4. PubMed ID: 12680154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.